Organoid study opens new avenues in pulmonary neuroendocrine cancer therapy

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Gene ther­a­py biotech Pas­sage Bio will let go about one-quar­ter of its work­force and is part­ing ways with two ex­ec­u­tives, nine months af­ter a new